Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 08:00 am Purchase | 13G | APREA THERAPEUTICS INC APRE | Sio Capital Management LLC | 280,000 7.490% | 280,000 (New Position) | View |
| 2024-02-14 08:00 am Purchase | 13G | Modular Medical Inc. MODD | Sio Capital Management LLC | 2,110,260 9.990% | 2,110,260 (New Position) | View |
| 2024-02-14 08:00 am Purchase | 13G | Gracell Biotechnologies Inc. GRCL | Sio Capital Management LLC | 25,007,900 5.200% | 25,007,900 (New Position) | View |
| 2023-02-13 1:24 pm Purchase | 13G | Modular Medical Inc. MODD | Sio Capital Management LLC | 1,091,479 9.990% | 1,091,479 (New Position) | View |
| 2022-02-10 4:05 pm Sale | 13G | SALARIUS PHARMACEUTICALS INC C SLRX | Sio Capital Management LLC | 1,354,291 3.000% | -302,951 (-18.28%) | View |
| 2022-02-10 4:02 pm Sale | 13G | CELLECTAR BIOSCIENCES INC CLRB | Sio Capital Management LLC | 0 0.000% | -2,331,123 (Position Closed) | View |
| 2022-02-10 4:01 pm Sale | 13G | CURIS INC PAR $0.01 CRIS | Sio Capital Management LLC | 3,866,645 4.220% | -889,793 (-18.71%) | View |
| 2021-02-16 1:03 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Sio Capital Management LLC | 2,331,123 8.690% | 2,331,123 (New Position) | View |
| 2021-02-16 1:03 pm Purchase | 13G | CURIS INC PAR $0.01 CRIS | Sio Capital Management LLC | 4,756,438 5.780% | 4,756,438 (New Position) | View |
| 2021-02-16 1:03 pm Purchase | 13G | LARIMAR THERAPEUTICS INC LRMR | Sio Capital Management LLC | 188,661 1.230% | 188,661 (New Position) | View |
| 2021-02-16 1:03 pm Purchase | 13G | SALARIUS PHARMACEUTICALS INC C SLRX | Sio Capital Management LLC | 1,657,242 8.350% | 1,657,242 (New Position) | View |
| 2020-02-14 4:00 pm Sale | 13G | ACHIEVE LIFE SCIENCES INC. ACHV | Sio Capital Management LLC | 0 0.000% | -597,373 (Position Closed) | View |
| 2020-02-14 4:00 pm Unchanged | 13G | FRESH TRACKS THERAPEUTICS INC FRTX | Sio Capital Management LLC | 0 0.000% | 0 (Unchanged) | View |
| 2020-02-14 4:00 pm Purchase | 13G | BIONANO GENOMICS INC BNGO | Sio Capital Management LLC | 1,210,821 4.570% | 495,979 (+69.38%) | View |
| 2020-02-14 4:00 pm Purchase | 13G | Trillium Therapeutics Inc. TRIL | Sio Capital Management LLC | 2,751,186 9.810% | 2,751,186 (New Position) | View |
| 2020-02-14 4:00 pm Purchase | 13G | LARIMAR THERAPEUTICS INC LRMR | Sio Capital Management LLC | 2,283,164 6.110% | 2,283,164 (New Position) | View |